Synedica Retatrutide Pen — Advanced Triple-Incretin Formula
High-dose Synedica Retatrutide Pen activating GLP-1, GIP and Glucagon receptors for maximum metabolic research impact.
Concentration & Quality
- 40 mg Retatrutide per prefilled pen
- Triple hormone pathway activation
- Synedica pharmaceutical quality standard
Key Features
- Highest dose Retatrutide pen for advanced research
- Targets GLP-1, GIP, and Glucagon receptors simultaneously
- Extended duration of action for long-term studies
How to Use
Prefilled pen — store refrigerated (2–8 °C). For research use only.
Reviews
There are no reviews yet.